Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Payables: 2018-2024

Historic Payables for Bicycle Therapeutics (BCYC) over the last 7 years, with Dec 2024 value amounting to $15.8 million.

  • Bicycle Therapeutics' Payables rose 121.44% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.8 million, marking a year-over-year increase of 73.74%. This contributed to the annual value of $15.8 million for FY2024, which is 21.02% up from last year.
  • As of FY2024, Bicycle Therapeutics' Payables stood at $15.8 million, which was up 21.02% from $13.1 million recorded in FY2023.
  • Over the past 5 years, Bicycle Therapeutics' Payables peaked at $15.8 million during FY2024, and registered a low of $1.4 million during FY2020.
  • In the last 3 years, Bicycle Therapeutics' Payables had a median value of $13.1 million in 2023 and averaged $11.8 million.
  • As far as peak fluctuations go, Bicycle Therapeutics' Payables decreased by 29.96% in 2020, and later soared by 137.85% in 2022.
  • Bicycle Therapeutics' Payables (Yearly) stood at $1.4 million in 2020, then skyrocketed by 99.34% to $2.7 million in 2021, then surged by 137.85% to $6.5 million in 2022, then spiked by 101.64% to $13.1 million in 2023, then rose by 21.02% to $15.8 million in 2024.